M-RCBG Senior Fellow-Led Study Group: Omar Robles

U.S. Pharmaceutical Regulation: Understanding the Policy, Law and Economics

Session 3: Innovation, Competition, and "Pay-for-Delay" in Prescription Pharmaceuticals

Thursday, November 4, 4:00-5:30pm
David Ellwood Democracy Lab, R-414 AB
Registration is encouraged via this FORM

M-RCBG Senior Fellow Omar Robles  (in person) will host a discussion with Bryan Gant, Partner at White & Case LLP (via Zoom). This study group will be an overview of how the Drug Price Competition and Patent Term Restoration Act has affected pharmaceutical innovation, competition, and given rise to so-called “Reverse Payment” or "Pay-for-Delay" settlement agreements.  We will explore the many questions surrounding these agreements, the pivotal ruling of the U.S. Supreme Court, the law and economics of settling patent cases, and other recent developments. 

Note: current restrictions allow only those with an HUID to enter the buildings and attend the session

Omar Robles headshot, outdoors with trees behind him, wearing a grey suit jacket, light blue shirt, dark blue necktie, and dark glassesOmar Robles is Managing Partner at Emerging Health LLC, a consulting firm dedicated to applying economic and strategic expertise to complex business and legal challenges in life sciences. Dr. Robles has consulted on numerous commercial litigations concerning prescription pharmaceuticals, medical devices, and dietary supplements. His engagements have concerned antitrust claims and intellectual property matters litigated in US federal and state courts, the US Patent Trial and Appeal Board, and Canadian courts. Dr. Robles’ research focuses on regulatory health policy, drug development, and competition in life sciences. His work has been published in peer-reviewed journals such as the American Economic Journal: Applied Economics and the Journal of Health Economics. In addition, Dr. Robles routinely publishes articles in legal news sources as a life sciences expert and has contributed to multiple publications from the American Bar Association. He also holds a Lecturer position at the University of California Berkeley School of Public Health where he provides graduate instruction on regulatory science and drug development. He has previously taught economics and public policy at Harvard University, Georgetown University, and the University of Maryland-College Park. In 2010, Dr. Robles received the prestigious Joseph R. Levenson Memorial Teaching Prize for excellence in teaching from the Harvard Undergraduate Council. Dr. Robles received his B.B.A. in finance and economics from the University of Wisconsin-Madison, his M.B.A. from DePaul University, and his M.A. and Ph.D. in economics from Harvard University. As a Senior Fellow, his research will focus on the role of regulatory policy on competition in prescription pharmaceuticals. Email: orobles@hks.harvard.edu